How does myTomorrows support expanded access programs?

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

1 mins read

share this post

We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas:

free-of-charge or paid-for
single patient or cohort programs
post-trial access

Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance.

share this post

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

more articles

view all blogs

Impact Support Clone of – Understanding glioblastoma recurrence and treatment options

sysadmin@impactmedia.co.uk

26 Feb 2025

6 mins read

myTomorrows Appoints Industry Leader Marshall Van Beurden as New Chief Technology Officer

myTomorrows Team

5 Jun 2024

3 mins read

A real-world data team member working at myTomorrows

Unlocking the potential of Real-World Evidence derived from Expanded Access Programs

myTomorrows Team

24 Apr 2024

8 mins read

myTomorrows and brainstrust Partner to Support the Brain Cancer Community in Accessing Clinical Trials

myTomorrows Team

4 Apr 2024

4 mins read

Know your options: Introducing our new website

myTomorrows Team

18 Mar 2024

3 mins read

myTomorrows Partners with The ALS Association to Support ALS Patients in Accessing Clinical Trials

myTomorrows Team

14 Mar 2024

4 mins read

Scientist in latex gloves working with stethoscope, test tube and flask.

Genetic Testing for Brain Cancer

myTomorrows Team

2 Feb 2024

13 mins read

What is Myotonic Dystrophy

myTomorrows Team

18 Jan 2024

13 mins read

Man in green t-shirt running past trees in a park as part of an exercise routine and health management for type 1 diabetes.

Diabetes Type 1 in Daily Life: What Patients Need to Know

myTomorrows Team

30 Nov 2023

10 mins read

myTomorrows announces partnership with Congenica

myTomorrows Team

13 Sep 2023

2 mins read

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.